UPDATED May 26, 2022
U.S. Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
TRECTrecora Resources | US$9.72 | 1.3% | 18.7% | US$229.9m | n/a | PS25.6x | n/a | n/a | Materials | ||
MYFWFirst Western Financial | US$31.00 | 1.6% | 11.0% | US$293.5m | US$42.67 | PB1.3x | E29.9% | n/a | Banks | ||
SWBISmith & Wesson Brands | US$15.12 | 10.3% | -28.5% | US$688.1m | US$21.67 | PS2.8x | E-53.6% | 2.1% | Consumer Durables | ||
VINPVinci Partners Investments | US$11.16 | 1.5% | -21.1% | US$622.8m | US$19.01 | PS14.4x | E18.1% | 6.9% | Diversified Financials | ||
EPACEnerpac Tool Group | US$20.20 | -1.6% | -26.3% | US$1.2b | US$20.50 | PS33x | E28.0% | 0.2% | Capital Goods | ||
AVPTAvePoint | US$5.54 | 9.1% | -46.6% | US$1.0b | US$8.00 | PS5x | E57.8% | n/a | Software | ||
KTTAPasithea Therapeutics | US$0.83 | -8.8% | n/a | US$19.2m | US$3.00 | PS671.8x | S112.3% | n/a | Pharmaceuticals & Biotech | ||
KTHNKatahdin Bankshares | US$23.00 | 1.1% | 4.9% | US$75.5m | n/a | PS8.5x | n/a | 2.4% | Banks | ||
ABMLAmerican Battery Technology | US$0.91 | -4.5% | -58.1% | US$587.3m | n/a | PB11.2x | n/a | n/a | Materials | ||
BABBBAB | US$0.92 | 5.1% | 27.8% | US$6.7m | n/a | PS17.6x | n/a | 4.3% | Consumer Services | ||
BTAE.FBeta Energy | US$1.28 | 116,263.6% | n/a | US$63.2m | n/a | PB8.7x | n/a | n/a | Energy | ||
LAAALakeshore Acquisition I | US$9.90 | 0.1% | n/a | US$70.2m | n/a | PB210.1x | n/a | n/a | Diversified Financials | ||
SCVLShoe Carnival | US$28.62 | 9.1% | -17.3% | US$789.6m | US$53.00 | PS5.7x | S5.6% | 1.3% | Retail | ||
UNFUniFirst | US$161.81 | 2.4% | -25.7% | US$3.0b | US$186.50 | PS23.6x | E18.4% | 0.7% | Commercial Services | ||
NECBNortheast Community Bancorp | US$11.10 | 3.2% | -10.4% | US$166.6m | US$13.00 | PS13.5x | E27.6% | 2.2% | Banks | ||
KRNTKornit Digital | US$40.49 | -5.4% | -61.0% | US$2.0b | US$81.50 | PS384.6x | E89.1% | n/a | Capital Goods | ||
IKNAIkena Oncology | US$3.23 | -12.7% | -83.1% | US$136.9m | US$24.33 | PS4.4x | E-28.6% | n/a | Pharmaceuticals & Biotech | ||
HAFCHanmi Financial | US$23.11 | 6.4% | 9.9% | US$698.5m | US$27.60 | PB1.1x | E-2.6% | 3.8% | Banks | ||
ZYMEZymeworks | US$6.37 | 9.5% | -78.7% | US$368.0m | US$26.73 | PS13.2x | E10.3% | n/a | Pharmaceuticals & Biotech | ||
HGBLHeritage Global | US$1.19 | 0% | -57.3% | US$43.6m | US$3.75 | PS16.4x | E44.8% | n/a | Diversified Financials | ||
LIDRAEye | US$5.30 | -1.3% | -47.0% | US$834.0m | US$12.00 | PS221.9x | E70.5% | n/a | Tech | ||
MNPRMonopar Therapeutics | US$2.25 | 0.4% | -61.0% | US$28.4m | US$26.50 | PB1.7x | E63.4% | n/a | Pharmaceuticals & Biotech | ||
COUVCorporate Universe | US$0.019 | -7.0% | -75.2% | US$9.8m | n/a | PB5.9x | n/a | n/a | Diversified Financials | ||
EFSCEnterprise Financial Services | US$45.90 | 6.3% | -6.8% | US$1.7b | US$55.00 | PB1.2x | E8.0% | 1.9% | Banks |